107 related articles for article (PubMed ID: 22454080)
1. NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity.
Wang H; Lee S; Nigro CL; Lattanzio L; Merlano M; Monteverde M; Matin R; Purdie K; Mladkova N; Bergamaschi D; Harwood C; Syed N; Szlosarek P; Briasoulis E; McHugh A; Thompson A; Evans A; Leigh I; Fleming C; Inman GJ; Hatzimichael E; Proby C; Crook T
Br J Cancer; 2012 Apr; 106(8):1446-52. PubMed ID: 22454080
[TBL] [Abstract][Full Text] [Related]
2. ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis.
Braganhol E; de Andrade GPB; Santos GT; Stefani MA
Purinergic Signal; 2024 Jun; 20(3):285-289. PubMed ID: 37402102
[TBL] [Abstract][Full Text] [Related]
3. Biomarker RIPK3 Is Silenced by Hypermethylation in Melanoma and Epigenetic Editing Reestablishes Its Tumor Suppressor Function.
Arroyo Villora S; Castellanos Silva P; Zenz T; Kwon JS; Schlaudraff N; Nitaj D; Meckbach C; Dammann R; Richter AM
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397165
[TBL] [Abstract][Full Text] [Related]
4. Detailed analysis of adenosine A2a receptor (
Vogt TJ; Gevensleben H; Dietrich J; Kristiansen G; Bootz F; Landsberg J; Goltz D; Dietrich D
Oncoimmunology; 2018; 7(8):e1452579. PubMed ID: 30221045
[No Abstract] [Full Text] [Related]
5. An Elf2-like transcription factor acts as repressor of the mouse ecto-5'-nucleotidase gene expression in hepatic myofibroblasts.
Fausther M; Lavoie EG; Goree JR; Dranoff JA
Purinergic Signal; 2017 Dec; 13(4):417-428. PubMed ID: 28667437
[TBL] [Abstract][Full Text] [Related]
6. An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma.
Davalos V; Lovell CD; Von Itter R; Dolgalev I; Agrawal P; Baptiste G; Kahler DJ; Sokolova E; Moran S; Piqué L; Vega-Saenz de Miera E; Fontanals-Cirera B; Karz A; Tsirigos A; Yun C; Darvishian F; Etchevers HC; Osman I; Esteller M; Schober M; Hernando E
Nat Commun; 2023 Apr; 14(1):1867. PubMed ID: 37015919
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.
Vizoso M; Ferreira HJ; Lopez-Serra P; Carmona FJ; Martínez-Cardús A; Girotti MR; Villanueva A; Guil S; Moutinho C; Liz J; Portela A; Heyn H; Moran S; Vidal A; Martinez-Iniesta M; Manzano JL; Fernandez-Figueras MT; Elez E; Muñoz-Couselo E; Botella-Estrada R; Berrocal A; Pontén F; Oord Jv; Gallagher WM; Frederick DT; Flaherty KT; McDermott U; Lorigan P; Marais R; Esteller M
Nat Med; 2015 Jul; 21(7):741-50. PubMed ID: 26030178
[TBL] [Abstract][Full Text] [Related]
8. GRHL2 suppression of NT5E/CD73 in breast cancer cells modulates CD73-mediated adenosine production and T cell recruitment.
Coban B; Wang Z; Liao CY; Beslmüller K; Timmermans MAM; Martens JWM; Hundscheid JHM; Slutter B; Zweemer AJM; Neubert E; Danen EHJ
iScience; 2024 May; 27(5):109738. PubMed ID: 38706844
[TBL] [Abstract][Full Text] [Related]
9. Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases.
Westphal D; Meinhardt M; Grützmann K; Schöne L; Steininger J; Neuhaus LT; Wiegel M; Schrimpf D; Aust DE; Schröck E; Baretton GB; Beissert S; Juratli TA; Schackert GG; Gravemeyer J; Becker JC; von Deimling A; Koelsche C; Klink B; Meier F; Schulz A; Muders MH; Seifert M
J Invest Dermatol; 2023 Jul; 143(7):1233-1245.e17. PubMed ID: 36716920
[TBL] [Abstract][Full Text] [Related]
10. Malignant carcinoma and skin melanoma neoplasms concomitantly in the thyroid.
Al-Harake A; Dandache I; Moukadem H; Saliba M; Chahine J; Yazbeck H; Abdel-Sater F; Karnib H; Younes MH
Clin Case Rep; 2021 Sep; 9(9):e04790. PubMed ID: 34552737
[TBL] [Abstract][Full Text] [Related]
11. CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer.
Loi S; Pommey S; Haibe-Kains B; Beavis PA; Darcy PK; Smyth MJ; Stagg J
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11091-6. PubMed ID: 23776241
[TBL] [Abstract][Full Text] [Related]
12. CD73 expression as a potential marker of good prognosis in breast carcinoma.
Supernat A; Markiewicz A; Welnicka-Jaskiewicz M; Seroczynska B; Skokowski J; Sejda A; Szade J; Czapiewski P; Biernat W; Zaczek A
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):103-7. PubMed ID: 22553809
[TBL] [Abstract][Full Text] [Related]
13. Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor.
Mittal D; Young A; Stannard K; Yong M; Teng MW; Allard B; Stagg J; Smyth MJ
Cancer Res; 2014 Jul; 74(14):3652-8. PubMed ID: 24986517
[TBL] [Abstract][Full Text] [Related]
14. Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis.
Wang L; Tang S; Wang Y; Xu S; Yu J; Zhi X; Ou Z; Yang J; Zhou P; Shao Z
Clin Exp Metastasis; 2013 Jun; 30(5):671-80. PubMed ID: 23508889
[TBL] [Abstract][Full Text] [Related]
15. Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses.
Beavis PA; Milenkovski N; Henderson MA; John LB; Allard B; Loi S; Kershaw MH; Stagg J; Darcy PK
Cancer Immunol Res; 2015 May; 3(5):506-17. PubMed ID: 25672397
[TBL] [Abstract][Full Text] [Related]
16. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.
Allard B; Pommey S; Smyth MJ; Stagg J
Clin Cancer Res; 2013 Oct; 19(20):5626-35. PubMed ID: 23983257
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CD73 in prostate cancer is associated with lymph node metastasis.
Yang Q; Du J; Zu L
Pathol Oncol Res; 2013 Oct; 19(4):811-4. PubMed ID: 23653114
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma.
Lu XX; Chen YT; Feng B; Mao XB; Yu B; Chu XY
World J Gastroenterol; 2013 Mar; 19(12):1912-8. PubMed ID: 23569336
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ectonucleotidases in human medulloblastoma cell lines: ecto-5'NT/CD73 in metastasis as potential prognostic factor.
Cappellari AR; Rockenbach L; Dietrich F; Clarimundo V; Glaser T; Braganhol E; Abujamra AL; Roesler R; Ulrich H; Battastini AM
PLoS One; 2012; 7(10):e47468. PubMed ID: 23094051
[TBL] [Abstract][Full Text] [Related]
20. NT5E CpG island methylation is a favourable breast cancer biomarker.
Lo Nigro C; Monteverde M; Lee S; Lattanzio L; Vivenza D; Comino A; Syed N; McHugh A; Wang H; Proby C; Garrone O; Merlano M; Hatzimichael E; Briasoulis E; Gojis O; Palmieri C; Jordan L; Quinlan P; Thompson A; Crook T
Br J Cancer; 2012 Jun; 107(1):75-83. PubMed ID: 22653144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
